KoBioLabs Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4,594	5,689	10,047	10,433	52,693
Short-Term Investments	41,501	50,141	56,194	82,514	33,989
Trading Asset Securities	1,006	-	-	-	2,003
Cash & Short-Term Investments	47,100	55,830	66,240	92,947	88,685
Cash Growth	-15.64%	-15.72%	-28.73%	4.81%	73.98%
Accounts Receivable	3,929	2,413	1,858	701.91	199.2
Other Receivables	601.29	917.9	3,020	4,279	3,118
Receivables	4,531	3,331	4,878	4,991	3,437
Inventory	5,710	4,468	1,467	977.47	256.21
Prepaid Expenses	1,332	910.68	1,765	1,852	2,133
Other Current Assets	1,264	2,143	1,378	1,711	4,108
Total Current Assets	59,936	66,682	75,729	102,478	98,619
Property, Plant & Equipment	29,194	31,172	34,858	20,485	5,791
Long-Term Investments	-0	2,560	2,484	0	0
Other Intangible Assets	774.39	642.24	637.67	279.6	324.2
Other Long-Term Assets	1,352	1,039	914.62	687.14	541.7
Total Assets	91,257	102,096	114,623	123,930	105,285
Accounts Payable	2.3	3.55	-	-	-
Accrued Expenses	1,839	1,756	1,127	763.8	543.31
Short-Term Debt	6,072	3,791	8,633	1,700	-
Current Portion of Long-Term Debt	917.94	3,830	58.36	-	1,515
Current Portion of Leases	245.4	130.21	234.21	136.51	24.6
Current Unearned Revenue	257.84	633.16	775.09	120.24	632.53
Other Current Liabilities	3,999	3,678	10,323	6,223	4,124
Total Current Liabilities	13,334	13,822	21,151	8,944	6,840
Long-Term Debt	6,427	8,671	9,172	11,765	7,633
Long-Term Leases	106.45	118.06	195.96	180.53	24.37
Pension & Post-Retirement Benefits	0	-0	0	-0	-
Other Long-Term Liabilities	22,121	24,007	22,285	7,586	200
Total Liabilities	41,989	46,618	52,804	28,475	14,697
Common Stock	9,709	9,687	9,436	8,722	8,135
Additional Paid-In Capital	215,454	215,260	219,114	220,581	208,053
Retained Earnings	-174,455	-168,125	-162,827	-148,975	-127,053
Comprehensive Income & Other	-18,400	-18,997	-21,022	-3,736	577.08
Total Common Equity	32,309	37,825	44,702	76,592	89,713
Minority Interest	16,866	17,558	16,868	18,132	-
Shareholders' Equity	49,268	55,477	61,819	95,455	90,589
Total Liabilities & Equity	91,257	102,096	114,623	123,930	105,285
Total Debt	13,769	16,540	18,294	13,782	9,197
Net Cash (Debt)	33,331	39,290	47,946	79,165	79,488
Net Cash Growth	-15.17%	-18.05%	-39.43%	-0.41%	56.20%
Net Cash Per Share	1716.62	2046.85	2587.95	4713.30	4953.80
Filing Date Shares Outstanding	19.45	19.37	18.87	17.44	16.27
Total Common Shares Outstanding	19.45	19.37	18.87	17.44	16.27
Working Capital	46,603	52,860	54,578	93,535	91,779
Book Value Per Share	1660.92	1952.37	2368.65	4390.83	5513.80
Tangible Book Value	31,534	37,183	44,064	76,312	89,388
Tangible Book Value Per Share	1621.11	1919.22	2334.86	4374.80	5493.88
Land	6,477	6,477	6,477	6,477	-
Buildings	14,364	14,308	16,563	5,925	-
Machinery	10,981	10,862	4,569	3,920	859.78
Construction In Progress	70.1	-	8,766	4,929	5,321

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.